Delivery Order 75N93019D00001-75N93020F00001

Award Date 6/25/20
Potential Completion Date 6/24/21
Potential Value $120K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Manassas, VA 20110, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $2,500 delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract to American Type Culture Collection, doing business as Atcc, located in Manassas, Virginia. The delivery order is for in vitro assessment for antimicrobial activity as described in the master IDIQ and will be performed by Atcc...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $213,244 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity master IDIQ contract. Colorado State University Sponsored Programs Division, doing business as Sponsored Programs and representing parent company Colorado State University System, will perform in vitro assessments of antimicrobial activity as outlined in the...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the American Type Culture Collection (ATCC). The contract is for in vitro assessments of antimicrobial activity, with a ceiling value of $177,137.49 and a period of performance from September 15, 2016 to September 15, 2017. The contract is a delivery order under the larger "In Vitro Antimicrobial Assessments...
This federal contract award, with an ID of 75N93019D00002|75N93022F00001, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The $3,266,305.22 delivery order was awarded to the American Type Culture Collection (ATCC), a non-profit organization that provides biological materials and services to government, academic, and industry customers. The contract is for the production of well-characterized...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a cost-plus-fixed-fee delivery order contract to the American Type Culture Collection (ATCC) for the production of well-characterized challenge materials (WCCM) of Biosafety Level 3 and 4 viruses. This order is placed under ATCC's existing In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite delivery, indefinite quantity (IDIQ)...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $2,500 delivery order against the In Vitro Assessments of Antimicrobial Activity master IDIQ contract to Colorado State University Sponsored Programs Division for in vitro assessments of antimicrobial activity. The firm fixed price order is being performed in Fort Collins, Colorado through September 30, 2020. As the prime contractor, Colorado State...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute. The $638,080 contract is for in vitro assessment of antimicrobial activity, under the In Vitro Antimicrobial Assessments 2011-2018 master IDIQ contract. The period of performance is from November 4, 2016 to October 31, 2017. AAHI is a prime contractor experienced in...
The American Type Culture Collection (ATCC), doing business as Atcc, was awarded a $2,500 delivery order against the In Vitro Assessments of Antimicrobial Activity (IVAAA) master indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The firm fixed price order is for in vitro assessments of antimicrobial...
This is a firm fixed-price task order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit organization, under the In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The task order is for $548,193.00 and is for in vitro antimicrobial assessment services to support NIAID's research and development activities, with a...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $371,424 firm fixed price delivery order to Southern Research Institute under the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity master contract vehicle. The delivery order is to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in Groups 8 and 9, as...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $119,600 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract vehicle. Under this order, the American Type Culture Collection will perform in vitro inhibitory effect determinations of experimental antibacterial substances against biodefense bacteria species including Bacillus anthracis, Yersinia pestis, Francisella tularensis, and Burkholderia m. The place of performance is the prime contractor's facility in Manassas, Virginia, with work to be completed by June 2021. This delivery order supports the NIH's research efforts to develop medical countermeasures against priority pathogens.

Generated 12/30/23, 6:12 PM